Archive · 6 Jan 2026
Mumbai Achieves Major MDR-TB Breakthrough with BPaL Regimen
Mumbai has made a big step forward in fighting a tough type of tuberculosis called MDR-TB.
The city's health department used a new treatment called BPaL, which helped cure 89 patients in just six months.
Before this, treating MDR-TB took much longer, up to two years.
The BPaL treatment uses only four medicines instead of more than ten.
The health department also made sure patients got regular check-ups, good food, and support to help them finish their treatment.
This success shows that with the right tools and care, even hard-to-treat diseases can be beaten.
Experts hope this will help fight TB not just in Mumbai but all over India.
89 MDR-TB patients cured in six months using the BPaL regimen in Mumbai.
BPaL regimen reduces treatment duration from 18-24 months to six months.
BPaL consists of four drugs: Pretomanid, Linezolid, Bedaquiline, and Moxifloxacin.
Holistic care including medical check-ups, nutritional support, and counselling reduces treatment dropouts.
Modern diagnostic technologies used for early identification and continuous monitoring of MDR-TB cases.
- Who
- Brihanmumbai Municipal Corporation (BMC) Health Department and MDR-TB patients in Mumbai
- What
- Successful treatment of 89 MDR-TB patients using the BPaL regimen
- When
- Over the past six months
- Where
- Mumbai, India
- Why
- To improve treatment outcomes and reduce the duration of treatment for MDR-TB patients
- Number of Patients Cured
- 89
- Treatment Duration
- 6 months
- BPaL Regimen Drugs
- Pretomanid, Linezolid, Bedaquiline, Moxifloxacin
- Previous Treatment Duration
- 18 to 24 months
- Support Provided
- Medical check-ups, nutritional support, counselling
- Diagnostic Tools
- Modern diagnostic technologies
- Clinical Trial Success Rate
- Nearly 90%